Skip Main Navigation
Page Content

Save This Event

Event Saved

Investor Spotlight: Novo Ventures

JLABS @ Toronto

Wednesday, May 30, 2018 from 10:30 AM to 1:00 PM (EDT)

Investor Spotlight: Novo Ventures

Ticket Information

Ticket Type Sales End Price * Fee Quantity
Presentation & Lunch   more info May 14, 2018 CA$15.00 CA$1.90
Media/Press   more info May 14, 2018 Free CA$0.00
Volunteer   more info May 8, 2018 Free CA$0.00
* Prices include GST/HST

Share Investor Spotlight: Novo Ventures

Event Details

Do you want to meet with one of the most active Life Science investors in the World? Novo Ventures is the venture investment vehicle for Novo Holdings A/S – a holding and investment company that manages ~$45B of assets on behalf of the Novo Nordisk Foundation.

Program Overview:

Novo Ventures is structured as an evergreen fund with an annual total of $350M to invest in private and public life science companies in North America and Europe. Their team identifies opportunities by leveraging a local presence in leading global biotech hubs and typically co-invests with other life sciences funds as either a lead or co-lead investor.

Novo Ventures has a strong focus on pre-commercial therapeutics and commercial med-tech companies, with opportunistic investments in diagnostics and research tools, and, more recently, digital health. Their team of professionals in Boston, Copenhagen, London and San Francisco has an active portfolio of more than 50 companies and has invested in more than 140 companies since 2000.

For more information on Novo Ventures, visit http://www.novo.dk/ventures/about.
 

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due May 11th, 2018. Apply Here. 

Speakers:
Nilesh Kumar | Partner, Novo Ventures read bio »
Ray Camahort | Senior Associate , Novo Ventures read bio »

Agenda:
10:30AM | Registration and Networking
11:00 AM | Presentation and Q&A
11:45 AM | Networking Lunch
12:00 PM | Program Close
1:00-5:00 PM | One-on-One Meetings*

*For pre-approved companies

Fees:
$15 | General Public

Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on May 29th (or sold out). 

Location:
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario 

Speakers:
Nilesh Kumar | Partner, Novo Ventures
Nilesh joined Novo Ventures (US) Inc. in Boston in 2015. Prior to joining Novo, Nilesh was Senior Director at MS Ventures where he invested in early stage life science companies. Nilesh led the initial investments and served on the Boards of Auxogyn, Canbex, f-Star, Raze Therapeutics, RaNA Therapeutics, Padlock Therapeutics and TocopheRx. In addition to his venture investment role, Nilesh has successfully led several strategic licensing transactions at Merck Serono in oncology and autoimmune therapeutic areas.

Nilesh received his PhD from the Department of Chemistry and Chemical Biology at Harvard University. He holds an MBA from Harvard University, and did his undergraduate degree in Natural Sciences from the University of Cambridge, UK.

^ Back to speakers' list ^

Ray Camahort | Senior Associate , Novo Ventures
Ray Camahort joined Novo Ventures in their Boston office in 2015, and is currently a Senior Associate with the firm.  Prior to joining Novo Ventures Ray was an Associate at the Harvard University Office of Technology Development where he worked to commercialize technologies developed in both the Chemistry and Stem Cell/Regenerative Biology departments. Ray completed a National Institute of Health (NIH) post-doctoral training fellowship at Harvard University and he was a pre-doctoral fellow at the Stowers Institute for Medical Research in Kansas City, Missouri.  He holds a PhD from the University of Kansas in biochemistry and molecular biology, and a BS in biological sciences from the University of California Santa Barbara.

^ Back to speakers' list ^

Have questions about Investor Spotlight: Novo Ventures? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where


JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1
Canada

Wednesday, May 30, 2018 from 10:30 AM to 1:00 PM (EDT)


  Add to my calendar

Organizer

JLABS @ Toronto

About Johnson & Johnson Innovation, JLABS
Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

About Johnson & Johnson Innovation
Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

  Contact the Organizer
Investor Spotlight: Novo Ventures
Things to do in Toronto Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.